Perfil
Tausif Butt currently works at Navigator Medicines, Inc., as Chief Executive Officer from 2025.
Mr. Butt also formerly worked at AstraZeneca PLC, as Senior Vice President-Latin America from 2019 to 2021, ChemoCentryx, Inc., as Chief Operating Officer & Executive Vice President from 2021 to 2022, and Idorsia Pharmaceuticals US, Inc., as President & General Manager.
Mr. Butt received his graduate degree from Imperial College London and undergraduate degree from the University of Brighton.
Cargos activos de Tausif Butt
| Empresas | Cargo | Inicio |
|---|
Antiguos cargos conocidos de Tausif Butt.
| Empresas | Cargo | Fin |
|---|---|---|
| CHEMOCENTRYX, INC. | Director de Operaciones | 20/10/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2021 |
Idorsia Pharmaceuticals US, Inc. | Presidente | - |
Formación de Tausif Butt.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Brighton
University of Brighton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idorsia Pharmaceuticals US, Inc. | Health Technology |
- Bolsa de valores
- Insiders
- Tausif Butt
















